SPOTLIGHT -
EP. 1: Multidisciplinary Care in Hepatocellular Carcinoma
EP. 2: Risk Factors for Hepatocellular Carcinoma
EP. 3: Diagnostic Workup for HCC
EP. 4: Resectability of HCC
EP. 5: Chemoembolization in Hepatocellular Carcinoma
EP. 6: Radioembolization in HCC
EP. 7: Radiographic Monitoring after Treatment in HCC
EP. 8: Systemic Therapy for Advanced HCC
EP. 9: Practical Views on Sorafenib in HCC
EP. 10: Managing Toxicities in Advanced HCC
EP. 11: Assessing Response to Sorafenib in Liver Cancers
EP. 12: Major Advances in Treatment of Hepatitis C Virus
EP. 13: Advances in Local-Regional Therapies for HCC
EP. 14: Advances in Systemic Therapy for HCC
EP. 15: The Future of Immunotherapy in HCC
Up-Front Osimertinib Provides Comparable OS, Improved Brain PFS Vs Sequential Gefitinib/Osimertinib in EGFR+ NSCLC
Dr Nasioudis on the Use of NGS to Identify the Molecular Profile of Endometroid Ovarian Cancer
Dr Buckingham on the Use of Patient-reported Outcomes to Predict Frailty in Patients With Ovarian Cancer
Dr Slomovitz on the Investigation of Letrozole Plus Ribociclib in Low-Grade Serous Ovarian Carcinoma
